GSK PLC/ GB00BN7SWP63 /
8/5/2024 11:59:40 AM | Chg. +4.00 | Volume | Bid11:59:52 AM | Ask11:59:51 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,563.50GBX | +0.26% | 384,755 Turnover(GBP): 6.01 mill. |
1,563.50Bid Size: 192 | 1,564.50Ask Size: 269 | 62.28 bill.GBP | - | - |
GlobeNewswire
7/1
Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire
6/20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
6/17
iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Pre...
GlobeNewswire
6/14
LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial
GlobeNewswire
6/14
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon...
GlobeNewswire
6/13
Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire
6/11
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
GlobeNewswire
6/4
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
GlobeNewswire
6/3
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
5/30
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth